MNI-672 SPECT imaging agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MNI-672 SPECT imaging agent, covering 2016-12-16 to 2016-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs. [Phase 1]